329 related articles for article (PubMed ID: 19520908)
21. Tadalafil therapy for pulmonary arterial hypertension.
Galiè N; Brundage BH; Ghofrani HA; Oudiz RJ; Simonneau G; Safdar Z; Shapiro S; White RJ; Chan M; Beardsworth A; Frumkin L; Barst RJ;
Circulation; 2009 Jun; 119(22):2894-903. PubMed ID: 19470885
[TBL] [Abstract][Full Text] [Related]
22. Prevention and treatment of high altitude pulmonary edema by a calcium channel blocker.
Oelz O; Maggiorini M; Ritter M; Noti C; Waber U; Vock P; Bärtsch P
Int J Sports Med; 1992 Oct; 13 Suppl 1():S65-8. PubMed ID: 1483797
[TBL] [Abstract][Full Text] [Related]
23. Lung diffusing capacity and exercise in subjects with previous high altitude pulmonary oedema.
Steinacker JM; Tobias P; Menold E; Reissnecker S; Hohenhaus E; Liu Y; Lehmann M; Bärtsch P; Swenson ER
Eur Respir J; 1998 Mar; 11(3):643-50. PubMed ID: 9596116
[TBL] [Abstract][Full Text] [Related]
24. Summaries for patients. A comparison of medications used to prevent high-altitude pulmonary edema.
Ann Intern Med; 2006 Oct; 145(7):I28. PubMed ID: 17015863
[No Abstract] [Full Text] [Related]
25. Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study.
Modesti PA; Vanni S; Morabito M; Modesti A; Marchetta M; Gamberi T; Sofi F; Savia G; Mancia G; Gensini GF; Parati G
Circulation; 2006 Sep; 114(13):1410-6. PubMed ID: 16982943
[TBL] [Abstract][Full Text] [Related]
26. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
27. Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes.
Faoro V; Huez S; Giltaire S; Pavelescu A; van Osta A; Moraine JJ; Guenard H; Martinot JB; Naeije R
J Appl Physiol (1985); 2007 Oct; 103(4):1161-5. PubMed ID: 17615281
[TBL] [Abstract][Full Text] [Related]
28. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
[TBL] [Abstract][Full Text] [Related]
29. The long-acting phosphodiesterase inhibitor tadalafil does not influence athletes' VO2max, aerobic, and anaerobic thresholds in normoxia.
Di Luigi L; Baldari C; Pigozzi F; Emerenziani GP; Gallotta MC; Iellamo F; Ciminelli E; Sgrò P; Romanelli F; Lenzi A; Guidetti L
Int J Sports Med; 2008 Feb; 29(2):110-5. PubMed ID: 17614028
[TBL] [Abstract][Full Text] [Related]
30. Exhaled nitric oxide and pulmonary artery pressures during graded ascent to high altitude.
Donnelly J; Cowan DC; Yeoman DJ; Lucas SJ; Herbison GP; Thomas KN; Ainslie PN; Taylor DR
Respir Physiol Neurobiol; 2011 Aug; 177(3):213-7. PubMed ID: 21515414
[TBL] [Abstract][Full Text] [Related]
31. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
Goudie AR; Lipworth BJ; Hopkinson PJ; Wei L; Struthers AD
Lancet Respir Med; 2014 Apr; 2(4):293-300. PubMed ID: 24717626
[TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase type 5 and high altitude pulmonary hypertension.
Aldashev AA; Kojonazarov BK; Amatov TA; Sooronbaev TM; Mirrakhimov MM; Morrell NW; Wharton J; Wilkins MR
Thorax; 2005 Aug; 60(8):683-7. PubMed ID: 16061711
[TBL] [Abstract][Full Text] [Related]
33. Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension.
Affuso F; Palmieri EA; Di Conza P; Guardasole V; Fazio S
Int J Cardiol; 2006 Apr; 108(3):429-31. PubMed ID: 16260051
[TBL] [Abstract][Full Text] [Related]
34. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.
Guazzi M; Tumminello G; Di Marco F; Fiorentini C; Guazzi MD
J Am Coll Cardiol; 2004 Dec; 44(12):2339-48. PubMed ID: 15607396
[TBL] [Abstract][Full Text] [Related]
35. [Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension].
Sakuma M; Shirato K
Nihon Rinsho; 2008 Nov; 66(11):2157-61. PubMed ID: 19051736
[TBL] [Abstract][Full Text] [Related]
36. Update on high-altitude pulmonary edema: pathogenesis, prevention, and treatment.
Stream JO; Grissom CK
Wilderness Environ Med; 2008; 19(4):293-303. PubMed ID: 19099331
[TBL] [Abstract][Full Text] [Related]
37. Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude.
Dehnert C; Grünig E; Mereles D; von Lennep N; Bärtsch P
Eur Respir J; 2005 Mar; 25(3):545-51. PubMed ID: 15738301
[TBL] [Abstract][Full Text] [Related]
38. Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans.
Basnyat B; Hargrove J; Holck PS; Srivastav S; Alekh K; Ghimire LV; Pandey K; Griffiths A; Shankar R; Kaul K; Paudyal A; Stasiuk D; Basnyat R; Davis C; Southard A; Robinson C; Shandley T; Johnson DW; Zafren K; Williams S; Weiss EA; Farrar JJ; Swenson ER
High Alt Med Biol; 2008; 9(3):209-16. PubMed ID: 18800957
[TBL] [Abstract][Full Text] [Related]
39. Comet tails in high-altitude pulmonary edema: diagnostic portent or streak in the sky?
Luks AM; Swenson ER
Chest; 2007 Apr; 131(4):951-3. PubMed ID: 17426194
[No Abstract] [Full Text] [Related]
40. Pulmonary vascular reserve and exercise capacity at sea level and at high altitude.
Pavelescu A; Faoro V; Guenard H; de Bisschop C; Martinot JB; Mélot C; Naeije R
High Alt Med Biol; 2013 Mar; 14(1):19-26. PubMed ID: 23537256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
